High-Risk Breast Cancer: Therapy
The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1991
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided to bring together a group of top researchers in breast cancer to provide a comprehensive, yet readable conceptual review of the state of the art of breast cancer diagnosis and therapy. The proposal to focus the review on the quantitative assessment of the risk at diagnosis, the determination of which may permit selective therapies for individual patients, was met with enthusiastic approval, resulting in the present volume with contributions by the leading investigators in the field. While the volume relating to diagnosis, published re cently, focused on efforts leading to refinement at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua tion of the first book. A refined risk assessment at diagnosis and the application of the most suitable treatments to well selected individuals are the most important steps towards avoiding the present worrisome reality of overtreating the low risk and undertreating the high-risk patients. The first few chapters of the present volume offer an insight into the general management of early breast cancer |
| Beschreibung: | 1 Online-Ressource (XIII, 517 p) |
| ISBN: | 9783642747281 |
| DOI: | 10.1007/978-3-642-74728-1 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046145091 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1991 |||| o||u| ||||||eng d | ||
| 020 | |a 9783642747281 |9 978-3-642-74728-1 | ||
| 024 | 7 | |a 10.1007/978-3-642-74728-1 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-74728-1 | ||
| 035 | |a (OCoLC)1118994944 | ||
| 035 | |a (DE-599)BVBBV046145091 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a XH 8450 |0 (DE-625)152958:13129 |2 rvk | ||
| 245 | 1 | 0 | |a High-Risk Breast Cancer |b Therapy |c edited by Joseph Ragaz, Irving M. Ariel |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1991 | |
| 300 | |a 1 Online-Ressource (XIII, 517 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided to bring together a group of top researchers in breast cancer to provide a comprehensive, yet readable conceptual review of the state of the art of breast cancer diagnosis and therapy. The proposal to focus the review on the quantitative assessment of the risk at diagnosis, the determination of which may permit selective therapies for individual patients, was met with enthusiastic approval, resulting in the present volume with contributions by the leading investigators in the field. While the volume relating to diagnosis, published re cently, focused on efforts leading to refinement at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua tion of the first book. A refined risk assessment at diagnosis and the application of the most suitable treatments to well selected individuals are the most important steps towards avoiding the present worrisome reality of overtreating the low risk and undertreating the high-risk patients. The first few chapters of the present volume offer an insight into the general management of early breast cancer | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Gynecology | |
| 650 | 4 | |a General Surgery | |
| 650 | 4 | |a Imaging / Radiology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Gynecology | |
| 650 | 4 | |a Surgery | |
| 650 | 4 | |a Radiology, Medical | |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Ragaz, Joseph |4 edt | |
| 700 | 1 | |a Ariel, Irving M. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642747304 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540510925 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642747298 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-74728-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031525276 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-642-74728-1 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180481338507264 |
|---|---|
| any_adam_object | |
| author2 | Ragaz, Joseph Ariel, Irving M. |
| author2_role | edt edt |
| author2_variant | j r jr i m a im ima |
| author_facet | Ragaz, Joseph Ariel, Irving M. |
| building | Verbundindex |
| bvnumber | BV046145091 |
| classification_rvk | XH 8450 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-74728-1 (OCoLC)1118994944 (DE-599)BVBBV046145091 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-74728-1 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03498nmm a2200565zc 4500</leader><controlfield tag="001">BV046145091</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1991 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642747281</subfield><subfield code="9">978-3-642-74728-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-74728-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-74728-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118994944</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145091</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8450</subfield><subfield code="0">(DE-625)152958:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">High-Risk Breast Cancer</subfield><subfield code="b">Therapy</subfield><subfield code="c">edited by Joseph Ragaz, Irving M. Ariel</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIII, 517 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided to bring together a group of top researchers in breast cancer to provide a comprehensive, yet readable conceptual review of the state of the art of breast cancer diagnosis and therapy. The proposal to focus the review on the quantitative assessment of the risk at diagnosis, the determination of which may permit selective therapies for individual patients, was met with enthusiastic approval, resulting in the present volume with contributions by the leading investigators in the field. While the volume relating to diagnosis, published re cently, focused on efforts leading to refinement at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua tion of the first book. A refined risk assessment at diagnosis and the application of the most suitable treatments to well selected individuals are the most important steps towards avoiding the present worrisome reality of overtreating the low risk and undertreating the high-risk patients. The first few chapters of the present volume offer an insight into the general management of early breast cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gynecology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General Surgery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Imaging / Radiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gynecology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Surgery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiology, Medical</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ragaz, Joseph</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ariel, Irving M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642747304</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540510925</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642747298</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-74728-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525276</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-74728-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046145091 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:27Z |
| institution | BVB |
| isbn | 9783642747281 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525276 |
| oclc_num | 1118994944 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XIII, 517 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| spelling | High-Risk Breast Cancer Therapy edited by Joseph Ragaz, Irving M. Ariel Berlin, Heidelberg Springer Berlin Heidelberg 1991 1 Online-Ressource (XIII, 517 p) txt rdacontent c rdamedia cr rdacarrier The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided to bring together a group of top researchers in breast cancer to provide a comprehensive, yet readable conceptual review of the state of the art of breast cancer diagnosis and therapy. The proposal to focus the review on the quantitative assessment of the risk at diagnosis, the determination of which may permit selective therapies for individual patients, was met with enthusiastic approval, resulting in the present volume with contributions by the leading investigators in the field. While the volume relating to diagnosis, published re cently, focused on efforts leading to refinement at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua tion of the first book. A refined risk assessment at diagnosis and the application of the most suitable treatments to well selected individuals are the most important steps towards avoiding the present worrisome reality of overtreating the low risk and undertreating the high-risk patients. The first few chapters of the present volume offer an insight into the general management of early breast cancer Oncology Gynecology General Surgery Imaging / Radiology Oncology Surgery Radiology, Medical Brustkrebs (DE-588)4008528-4 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Brustkrebs (DE-588)4008528-4 s Therapie (DE-588)4059798-2 s DE-604 Ragaz, Joseph edt Ariel, Irving M. edt Erscheint auch als Druck-Ausgabe 9783642747304 Erscheint auch als Druck-Ausgabe 9783540510925 Erscheint auch als Druck-Ausgabe 9783642747298 https://doi.org/10.1007/978-3-642-74728-1 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | High-Risk Breast Cancer Therapy Oncology Gynecology General Surgery Imaging / Radiology Oncology Surgery Radiology, Medical Brustkrebs (DE-588)4008528-4 gnd Therapie (DE-588)4059798-2 gnd |
| subject_GND | (DE-588)4008528-4 (DE-588)4059798-2 |
| title | High-Risk Breast Cancer Therapy |
| title_auth | High-Risk Breast Cancer Therapy |
| title_exact_search | High-Risk Breast Cancer Therapy |
| title_full | High-Risk Breast Cancer Therapy edited by Joseph Ragaz, Irving M. Ariel |
| title_fullStr | High-Risk Breast Cancer Therapy edited by Joseph Ragaz, Irving M. Ariel |
| title_full_unstemmed | High-Risk Breast Cancer Therapy edited by Joseph Ragaz, Irving M. Ariel |
| title_short | High-Risk Breast Cancer |
| title_sort | high risk breast cancer therapy |
| title_sub | Therapy |
| topic | Oncology Gynecology General Surgery Imaging / Radiology Oncology Surgery Radiology, Medical Brustkrebs (DE-588)4008528-4 gnd Therapie (DE-588)4059798-2 gnd |
| topic_facet | Oncology Gynecology General Surgery Imaging / Radiology Oncology Surgery Radiology, Medical Brustkrebs Therapie |
| url | https://doi.org/10.1007/978-3-642-74728-1 |
| work_keys_str_mv | AT ragazjoseph highriskbreastcancertherapy AT arielirvingm highriskbreastcancertherapy |